Tools for Cardiovascular Risk Assessment in Clinical Practice
作者： Miguel Cainzos-Achirica , Kieran Eissler , Michael J Blaha , Roger S Blumenthal , Seth S Martin
DOI: 10.1007/S12170-015-0455-4
关键词:
摘要: Precise risk stratification of atherosclerotic cardiovascular disease guides best management and therefore is a public health priority. In addition to estimation using traditional factors, tools such as coronary artery calcium, high-sensitivity C-reactive protein, ankle-brachial index carotid imaging, clinical features family history premature heart may offer opportunities for more personalized assessment. this review, we discuss the strengths limitations each these tools, focusing on evidence provided by latest studies relevant field. Among them, calcium currently stands out most powerful tool assessment, recognized 2013 ACC/AHA Risk Assessment Guideline. Recent have expanded our knowledge regarding its value improving detection both low high absolute within clinically subgroups, well cost-effectively guiding preventive therapy allocation.
springer.com
elsevier.com
sci-hub.se 参考文章(104)
Rolf M. Gunner, Roberta G. Williams, 25th Bethesda Conference: Future Personnel Needs for Cardiovascular Health Care November 15 to 16, 1993 Journal of the American College of Cardiology. ,vol. 24, pp. 275- 279 ,(1994) , 10.1016/0735-1097(94)90276-3
Ashleigh O. Gibson, Michael J. Blaha, Martinson K. Arnan, Ralph L. Sacco, Moyses Szklo, David M. Herrington, Joseph Yeboah, Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. The MESA Study. Jacc-cardiovascular Imaging. ,vol. 7, pp. 1108- 1115 ,(2014) , 10.1016/J.JCMG.2014.07.009
Omair Yousuf, Bibhu D Mohanty, Seth S Martin, Parag H Joshi, Michael J Blaha, Khurram Nasir, Roger S Blumenthal, Matthew J Budoff, None, High-sensitivity C-reactive protein and cardiovascular disease: A resolute belief or an elusive link? Journal of the American College of Cardiology. ,vol. 62, pp. 397- 408 ,(2013) , 10.1016/J.JACC.2013.05.016
Raimund Erbel, Stefan Möhlenkamp, Susanne Moebus, Axel Schmermund, Nils Lehmann, Andreas Stang, Nico Dragano, Dietrich Grönemeyer, Rainer Seibel, Hagen Kälsch, Martina Bröcker-Preuss, Klaus Mann, Johannes Siegrist, Karl-Heinz Jöckel, Heinz Nixdorf Recall Study Investigative Group, Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. Journal of the American College of Cardiology. ,vol. 56, pp. 1397- 1406 ,(2010) , 10.1016/J.JACC.2010.06.030
Charalambos Vlachopoulos, Konstantinos Aznaouridis, Christodoulos Stefanadis, Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. Journal of the American College of Cardiology. ,vol. 55, pp. 1318- 1327 ,(2010) , 10.1016/J.JACC.2009.10.061
Earl S Ford, Wayne H Giles, Ali H Mokdad, None, The distribution of 10-Year risk for coronary heart disease among U.S. adults: Findings from the National Health and Nutrition Examination Survey III Journal of the American College of Cardiology. ,vol. 43, pp. 1791- 1796 ,(2004) , 10.1016/J.JACC.2003.11.061
, C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction The New England Journal of Medicine. ,vol. 367, pp. 1310- 1320 ,(2012) , 10.1056/NEJMOA1107477
Michael G Silverman, James R Harkness, Ron Blankstein, Matthew J Budoff, Arthur S Agatston, J Jeffrey Carr, Joao A Lima, Roger S Blumenthal, Khurram Nasir, Michael J Blaha, None, Baseline Subclinical Atherosclerosis Burden and Distribution Are Associated With Frequency and Mode of Future Coronary Revascularization: Multi-Ethnic Study of Atherosclerosis Jacc-cardiovascular Imaging. ,vol. 7, pp. 476- 486 ,(2014) , 10.1016/J.JCMG.2014.03.005
Márcio Sommer Bittencourt, Michael J. Blaha, Ron Blankstein, Matthew Budoff, Jose D. Vargas, Roger S. Blumenthal, Arthur S. Agatston, Khurram Nasir, Polypill Therapy, Subclinical Atherosclerosis, and Cardiovascular Events—Implications for the Use of Preventive Pharmacotherapy Journal of the American College of Cardiology. ,vol. 63, pp. 434- 443 ,(2014) , 10.1016/J.JACC.2013.08.1640
Donald M Lloyd-Jones, David Goff, Neil J Stone, Statins, risk assessment, and the new American prevention guidelines The Lancet. ,vol. 383, pp. 600- 602 ,(2014) , 10.1016/S0140-6736(13)62348-X